Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein

In conclusion, the currently used drugs against SARS‐CoV‐2 have potential side effects. Vaccine trials have started against COVID‐19, but the host immune response against SARS‐CoV‐2 is not fully understood. It differs between individuals, and also re‐infection of individuals with SARS‐CoV‐2. For the first time, our results demonstrate that bromelain can inhibit SARS‐CoV‐2 infection via targetingContinue reading “Bromelain inhibits SARS‐CoV‐2 infection via targeting ACE‐2, TMPRSS2, and spike protein”